Talphera TLPH
NASDAQ TLPH
$1.19 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Talphera (TLPH) Cash from Investing Activities (2010 - 2026)

Talphera (TLPH) posted quarterly Cash from Investing Activities of -$2.7 million for Q1 2026, down 178.21% quarter-over-quarter from $3.5 million in Q4 2025.

Talphera (TLPH) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Talphera's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$17.1 million (down 362.0% YoY), while the FY2025 annual figure was -$14.3 million, down 479.4% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$2.7 million, down from $3.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $20.2 million in Q1 2022, with the low at -$17.8 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is $2.7 million (2022), against an average of $1.7 million.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 283.28% in 2022, then sank 3069.17% in 2025.
  • Talphera's Cash from Investing Activities stood at $2.7 million in 2022, then slumped by 237.26% to -$3.7 million in 2023, then surged by 116.43% to $600000.0 in 2024, then soared by 478.33% to $3.5 million in 2025, then slumped by 178.21% to -$2.7 million in 2026.
  • Business Quant data shows TLPH's Cash from Investing Activities at -$2.7 million in Q1 2026, $3.5 million in Q4 2025, and -$17.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Talphera 90.25 Mn 90.25 Mn - 1.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Jun 30, 2026 1.10 Mn
Mar 31, 2026 -2.71 Mn
Mar 31, 2026 -2.71 Mn
Dec 31, 2025 3.47 Mn
Dec 31, 2025 3.47 Mn
Sep 30, 2025 -17.82 Mn
Sep 30, 2025 -17.82 Mn
Sep 30, 2024 600,000.00
Sep 30, 2024 600,000.00
Jun 30, 2024 5.91 Mn
Jun 30, 2024 5.91 Mn
Mar 31, 2024 -2.73 Mn
Mar 31, 2024 -2.73 Mn
Dec 31, 2023 -3.65 Mn
Dec 31, 2023 -3.65 Mn
Jun 30, 2023 2.72 Mn
Jun 30, 2023 2.72 Mn
Mar 31, 2023 400,000.00
Mar 31, 2023 400,000.00